Biostax Corp. engages in the acquisition, development, and commercialization of pharmaceutical and biotechnology products. Its partnered programs include JKB-122, Londonal, and Low Dose Naltrexone. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Winter Park, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Immune Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Immune Therapeutics Inc market cap is $7,900.00.
What is the 52-week high for Immune Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Immune Therapeutics Inc 52 week high is $0.05 as of September 28, 2025.
What is the 52-week low for Immune Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Immune Therapeutics Inc 52 week low is $0.0001 as of September 28, 2025.
What is Immune Therapeutics Inc stock price today?
Immune Therapeutics Inc stock price today is $0.0601.
What was Immune Therapeutics Inc stock price yesterday?
Immune Therapeutics Inc stock price yesterday was $0.07.
What is the PE ratio of Immune Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Immune Therapeutics Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Immune Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Immune Therapeutics Inc P/B ratio is -0.0016.
What is the 50-day moving average of Immune Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Immune Therapeutics Inc 50-day moving average is $0.0002.